Eyenovia and Senju to develop chronic dry eye drop-device combo
Pipeline

Eyenovia and Senju to develop chronic dry eye drop-device combo

Collaboration features the Optejet dosing delivery system delivering a corneal epithelial wound healing-ophthalmic solution.
Osheru raises $4.7M to advance blepharoplasty surgical device
Products

Osheru raises $4.7M to advance blepharoplasty surgical device

Funding supports development and commercialization of Ziplyft, a first-of-its-kind, minimally-invasive alternative for eyelid surgery.
ADHD medications may lead to increased glaucoma risk
Research

ADHD medications may lead to increased glaucoma risk

New research investigates the potential link in newly-prescribed meds and development of angle-closure and open-angle glaucoma.
Systemic factors tied to retinal microvascular parameters in diabetic patients
Research

Systemic factors tied to retinal microvascular parameters in diabetic patients

New research shows potential relationship between diabetes, perfusion density, and vascular density.
Spryte Medical earns FDA Breakthrough Device Designation for nOCT tech
Products

Spryte Medical earns FDA Breakthrough Device Designation for nOCT tech

Company’s neuro OCT platform captures high-resolution, intravascular imaging inside the brain.
Investors and key therapeutic areas are determining the state of the ophthalmic market
Events

Investors and key therapeutic areas are determining the state of the ophthalmic market

Industry expert highlights current and future market numbers, innovation themes, and trends in therapeutic areas.
Physically active kids less likely to develop myopia
Research

Physically active kids less likely to develop myopia

Cross-sectional study investigates physical activity’s effect on childhood myopia prevalence
FDA clears Oertli's Faros anterior cataract surgery system
Products

FDA clears Oertli's Faros anterior cataract surgery system

Latest surgical system features a compact design and offers rapid operational readiness in under 1 minute.
Vabysmo provides long-term durability in DME extension study
Research

Vabysmo provides long-term durability in DME extension study

Four-year data finds nearly 80% of patients extended treatment intervals to 3 or 4 months, with 90% reporting absence of DME.
Study: Dementia may be tied to declining visual function
Research

Study: Dementia may be tied to declining visual function

Worse baseline VA and CS were associated with increased risk of dementia, among other findings.
Bausch + Lomb acquires Trukera Medical
Business

Bausch + Lomb acquires Trukera Medical

Purchase of the former TearLab Corporation includes the ScoutPro Osmolarity System, a point-of-care portable device for osmolarity testing.
Opthea selects global retinal leaders for Medical Advisory Board
Business

Opthea selects global retinal leaders for Medical Advisory Board

Newly-formed board is led by Chief Medical Advisor Arshad M. Khanani, MD, MA, FASRS.
Robot system for wet AMD may lead to fewer injection treatments
Research

Robot system for wet AMD may lead to fewer injection treatments

Researchers examined potential benefits of radiotherapy for nAMD delivered with a robotically-controlled device.
SUSVIMO phase 3 data supports sustained efficacy for DR, DME
Products

SUSVIMO phase 3 data supports sustained efficacy for DR, DME

FDA has also accepted Genentech’s sBLA for the sustained-release drug delivery system’s diabetic eye disease indications.
Registration opens for Eyes On Retina 2024
Events

Registration opens for Eyes On Retina 2024

This year’s largest virtual retina event of the year kicks off in September.
Research identifies link between DED and chronic pain
Research

Research identifies link between DED and chronic pain

Investigators assess the prevalence and severity of dry eye symptoms in individuals with chronic pain.
Sydnexis names long-time industry executive as new leader
Business

Sydnexis names long-time industry executive as new leader

Effective Aug. 5, Perry J. Sternberg will take over as CEO of the pediatric myopia-focused pharmaceutical company.
Fuch's dystrophy may be accelerated among certain patient demographics
Research

Fuch's dystrophy may be accelerated among certain patient demographics

Study investigates link between FECD and demographic factors such as BMI.
Experts weigh in on key trends in anterior segment innovations
Events

Experts weigh in on key trends in anterior segment innovations

Ophthalmic leaders cover market opportunities, bridging the gap between physicians and industry, as well as premium patient outcomes for the future.
EssilorLuxottica is purchasing a majority stake in Heidelberg Engineering
Business

EssilorLuxottica is purchasing a majority stake in Heidelberg Engineering

Multinational eyewear corporation will acquire an 80% stake in the high-tech solutions company.